BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 38231217)

  • 1. Pathogenomics of Helicobacter pylori.
    Yamaoka Y; Saruuljavkhlan B; Alfaray RI; Linz B
    Curr Top Microbiol Immunol; 2023; 444():117-155. PubMed ID: 38231217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric Epithelial Barrier Disruption, Inflammation and Oncogenic Signal Transduction by Helicobacter pylori.
    Naumann M; Ferino L; Sharafutdinov I; Backert S
    Curr Top Microbiol Immunol; 2023; 444():207-238. PubMed ID: 38231220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategies for Helicobacter pylori isolation and sequencing analysis for virulence genes contributing to its pathogenicity.
    Al-Jumaily AY; Al-Haddad A; Al-Jubori SS
    Mol Biol Rep; 2024 Jan; 51(1):95. PubMed ID: 38194007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity and Functional Importance of Helicobacter pylori Virulence Factors.
    Sgouras D; Tegtmeyer N; Wessler S
    Adv Exp Med Biol; 2019; 1149():35-56. PubMed ID: 31016624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders.
    Nejati S; Karkhah A; Darvish H; Validi M; Ebrahimpour S; Nouri HR
    Microb Pathog; 2018 Apr; 117():43-48. PubMed ID: 29432909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island.
    Olbermann P; Josenhans C; Moodley Y; Uhr M; Stamer C; Vauterin M; Suerbaum S; Achtman M; Linz B
    PLoS Genet; 2010 Aug; 6(8):e1001069. PubMed ID: 20808891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Cag pathogenicity island in Helicobacter pylori from naturally infected rhesus macaques.
    Skoog EC; Deck SL; Entwistle HD; Hansen LM; Solnick JV
    FEMS Microbiol Lett; 2016 Dec; 363(24):. PubMed ID: 27940463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Pathogenesis, Molecular Mechanisms of Gastric Cancer Development.
    Wroblewski LE; Peek RM
    Curr Top Microbiol Immunol; 2023; 444():25-52. PubMed ID: 38231214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomes of Helicobacter pylori from native Peruvians suggest admixture of ancestral and modern lineages and reveal a western type cag-pathogenicity island.
    Devi SM; Ahmed I; Khan AA; Rahman SA; Alvi A; Sechi LA; Ahmed N
    BMC Genomics; 2006 Jul; 7():191. PubMed ID: 16872520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil.
    Ogura K; Maeda S; Nakao M; Watanabe T; Tada M; Kyutoku T; Yoshida H; Shiratori Y; Omata M
    J Exp Med; 2000 Dec; 192(11):1601-10. PubMed ID: 11104802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori virulence markers in gastroduodenal disorders. Detection of cytotoxin-associated gene A and vacuolating cytotoxin-associated gene A genes in Saudi patients.
    Al-Khattaf AS
    Saudi Med J; 2012 Jul; 33(7):716-21. PubMed ID: 22821304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection.
    Nell S; Estibariz I; Krebes J; Bunk B; Graham DY; Overmann J; Song Y; Spröer C; Yang I; Wex T; Korlach J; Malfertheiner P; Suerbaum S
    Gastroenterology; 2018 Feb; 154(3):612-623.e7. PubMed ID: 29066327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservation of the cag pathogenicity island is associated with vacA alleles and gastroduodenal disease in South African Helicobacter pylori isolates.
    Kidd M; Lastovica AJ; Atherton JC; Louw JA
    Gut; 2001 Jul; 49(1):11-7. PubMed ID: 11413104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany.
    Miehlke S; Kirsch C; Agha-Amiri K; Günther T; Lehn N; Malfertheiner P; Stolte M; Ehninger G; Bayerdörffer E
    Int J Cancer; 2000 Aug; 87(3):322-7. PubMed ID: 10897035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases.
    Rudi J; Kolb C; Maiwald M; Kuck D; Sieg A; Galle PR; Stremmel W
    J Clin Microbiol; 1998 Apr; 36(4):944-8. PubMed ID: 9542913
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Mohammadzadeh R; Menbari S; Pishdadian A; Farsiani H
    Expert Rev Mol Med; 2023 Jun; 25():e23. PubMed ID: 37309681
    [No Abstract]   [Full Text] [Related]  

  • 17. [The heterogeneity of genetic variants of Helicobacter pylori in patients with various acid-related diseases].
    Domracheva EV; Sarsenbaeva AS; Ufimtsev KA
    Eksp Klin Gastroenterol; 2014; (11):8-13. PubMed ID: 25842656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Helicobacter pylori Type IV Secretion System Encoded by the cag Pathogenicity Island: Architecture, Function, and Signaling.
    Backert S; Haas R; Gerhard M; Naumann M
    Curr Top Microbiol Immunol; 2017; 413():187-220. PubMed ID: 29536360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors.
    Franco AT; Johnston E; Krishna U; Yamaoka Y; Israel DA; Nagy TA; Wroblewski LE; Piazuelo MB; Correa P; Peek RM
    Cancer Res; 2008 Jan; 68(2):379-87. PubMed ID: 18199531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
    Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
    Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.